News
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...
11d
The Christian Post on MSNFDA Commissioner Marty Makary vows to launch review of abortion drug mifepristoneThe head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...
Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who, Trump tapped to lead the FDA, clarified the recently changed ...
Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results